These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38157015)
1. Inhibitor design for TMPRSS2: insights from computational analysis of its backbone hydrogen bonds using a simple descriptor. Ugrani S Eur Biophys J; 2024 Feb; 53(1-2):27-46. PubMed ID: 38157015 [TBL] [Abstract][Full Text] [Related]
2. Targeting mechanism for SARS-CoV-2 Zhao X; Luo S; Huang K; Xiong D; Zhang JZH; Duan L Nanoscale; 2021 Nov; 13(45):19218-19237. PubMed ID: 34787160 [TBL] [Abstract][Full Text] [Related]
3. Pharmacoinformatics-based identification of transmembrane protease serine-2 inhibitors from Morus Alba as SARS-CoV-2 cell entry inhibitors. Shakya A; Chikhale RV; Bhat HR; Alasmary FA; Almutairi TM; Ghosh SK; Alhajri HM; Alissa SA; Nagar S; Islam MA Mol Divers; 2022 Feb; 26(1):265-278. PubMed ID: 33786727 [TBL] [Abstract][Full Text] [Related]
4. Structural insights and inhibition mechanism of TMPRSS2 by experimentally known inhibitors Camostat mesylate, Nafamostat and Bromhexine hydrochloride to control SARS-coronavirus-2: A molecular modeling approach. Sonawane KD; Barale SS; Dhanavade MJ; Waghmare SR; Nadaf NH; Kamble SA; Mohammed AA; Makandar AM; Fandilolu PM; Dound AS; Naik NM; More VB Inform Med Unlocked; 2021; 24():100597. PubMed ID: 34075338 [TBL] [Abstract][Full Text] [Related]
5. Strong Binding of Leupeptin with TMPRSS2 Protease May Be an Alternative to Camostat and Nafamostat for SARS-CoV-2 Repurposed Drug: Evaluation from Molecular Docking and Molecular Dynamics Simulations. Ramakrishnan J; Kandasamy S; Iruthayaraj A; Magudeeswaran S; Chinnasamy K; Poomani K Appl Biochem Biotechnol; 2021 Jun; 193(6):1909-1923. PubMed ID: 33512650 [TBL] [Abstract][Full Text] [Related]
6. Relaxed complex scheme and molecular dynamics simulation suggests small molecule inhibitor of human TMPRSS2 for combating COVID-19. Vuai SAH; Ogedjo MM; Isaac O; Sahini MG; Swai HS; Shadrack DM J Biomol Struct Dyn; 2022; 40(24):13925-13935. PubMed ID: 34751094 [TBL] [Abstract][Full Text] [Related]
7. In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19. Wang S; Fang X; Wang Y Molecules; 2022 Jun; 27(13):. PubMed ID: 35807455 [TBL] [Abstract][Full Text] [Related]
8. Molecular docking analysis reveals the functional inhibitory effect of Genistein and Quercetin on TMPRSS2: SARS-COV-2 cell entry facilitator spike protein. Manjunathan R; Periyaswami V; Mitra K; Rosita AS; Pandya M; Selvaraj J; Ravi L; Devarajan N; Doble M BMC Bioinformatics; 2022 May; 23(1):180. PubMed ID: 35578172 [TBL] [Abstract][Full Text] [Related]
9. Structural Basis of Covalent Inhibitory Mechanism of TMPRSS2-Related Serine Proteases by Camostat. Sun G; Sui Y; Zhou Y; Ya J; Yuan C; Jiang L; Huang M J Virol; 2021 Sep; 95(19):e0086121. PubMed ID: 34160253 [TBL] [Abstract][Full Text] [Related]
11. Exploring the phytochemicals of Gurung AB; Ali MA; Lee J; Aljowaie RM; Almutairi SM J King Saud Univ Sci; 2022 Aug; 34(6):102155. PubMed ID: 35702062 [No Abstract] [Full Text] [Related]
12. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19. Li K; Meyerholz DK; Bartlett JA; McCray PB mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553 [TBL] [Abstract][Full Text] [Related]
14. Virtual Screening on Marine Natural Products for Discovering TMPRSS2 Inhibitors. Mahmudpour M; Nabipour I; Keshavarz M; Farrokhnia M Front Chem; 2021; 9():722633. PubMed ID: 34712648 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential Indonesian marine invertebrate bioactive compounds as TMPRSS2 and SARS-CoV-2 Omicron spike protein inhibitors through computational screening. Rizka Nurcahyaningtyas H; Irene A; Tri Wibowo J; Yunovilsa Putra M; Yanuar A Arab J Chem; 2023 Sep; 16(9):104984. PubMed ID: 37234226 [TBL] [Abstract][Full Text] [Related]
17. Identification of 13 Guanidinobenzoyl- or Aminidinobenzoyl-Containing Drugs to Potentially Inhibit TMPRSS2 for COVID-19 Treatment. Huang X; Pearce R; Omenn GS; Zhang Y Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209110 [TBL] [Abstract][Full Text] [Related]
18. A quantum chemical study on the anti-SARS-CoV-2 activity of TMPRSS2 inhibitors. Kondo A; Fujimoto KJ; Yanai T Phys Chem Chem Phys; 2023 Aug; 25(30):20597-20605. PubMed ID: 37477571 [TBL] [Abstract][Full Text] [Related]
19. Identification of novel TMPRSS2 inhibitors against SARS-CoV-2 infection: a structure-based virtual screening and molecular dynamics study. Manandhar S; Pai KSR; Krishnamurthy PT; Kiran AVVVR; Kumari GK Struct Chem; 2022; 33(5):1529-1541. PubMed ID: 35345416 [TBL] [Abstract][Full Text] [Related]
20. Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture. Wettstein L; Knaff PM; Kersten C; Müller P; Weil T; Conzelmann C; Müller JA; Brückner M; Hoffmann M; Pöhlmann S; Schirmeister T; Landfester K; Münch J; Mailänder V Commun Biol; 2022 Jul; 5(1):681. PubMed ID: 35804152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]